De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

InnoTek Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

InnoTek heeft een totaal eigen vermogen van SGD174.1M en een totale schuld van SGD9.0M, wat de schuld-eigenvermogensverhouding op 5.2% brengt. De totale activa en totale passiva bedragen respectievelijk SGD278.1M en SGD104.0M. De EBIT InnoTek is SGD4.0M waardoor de rentedekking 18.9 is. Het heeft contanten en kortetermijnbeleggingen van SGD64.9M.

Belangrijke informatie

5.2%

Verhouding schuld/eigen vermogen

S$9.00m

Schuld

Rente dekkingsratio18.9x
ContantS$64.93m
AandelenS$174.09m
Totaal verplichtingenS$104.03m
Totaal activaS$278.12m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Shareholders May Be Wary Of Increasing InnoTek Limited's (SGX:M14) CEO Compensation Package

Apr 21
Shareholders May Be Wary Of Increasing InnoTek Limited's (SGX:M14) CEO Compensation Package

InnoTek's (SGX:M14) Performance Is Even Better Than Its Earnings Suggest

Apr 18
InnoTek's (SGX:M14) Performance Is Even Better Than Its Earnings Suggest

InnoTek Limited's (SGX:M14) Shares May Have Run Too Fast Too Soon

Apr 11
InnoTek Limited's (SGX:M14) Shares May Have Run Too Fast Too Soon

The Returns On Capital At InnoTek (SGX:M14) Don't Inspire Confidence

Mar 08
The Returns On Capital At InnoTek (SGX:M14) Don't Inspire Confidence

InnoTek (SGX:M14) Is Looking To Continue Growing Its Returns On Capital

Jun 04
InnoTek (SGX:M14) Is Looking To Continue Growing Its Returns On Capital

At S$0.80, Is It Time To Put InnoTek Limited (SGX:M14) On Your Watch List?

Apr 13
At S$0.80, Is It Time To Put InnoTek Limited (SGX:M14) On Your Watch List?

Did You Participate In Any Of InnoTek's (SGX:M14) Incredible 476% Return?

Mar 18
Did You Participate In Any Of InnoTek's (SGX:M14) Incredible 476% Return?

InnoTek Limited's (SGX:M14) Intrinsic Value Is Potentially 43% Above Its Share Price

Mar 05
InnoTek Limited's (SGX:M14) Intrinsic Value Is Potentially 43% Above Its Share Price

Is There More Growth In Store For InnoTek's (SGX:M14) Returns On Capital?

Feb 20
Is There More Growth In Store For InnoTek's (SGX:M14) Returns On Capital?

Does InnoTek Limited (SGX:M14) Have A Place In Your Dividend Portfolio?

Feb 01
Does InnoTek Limited (SGX:M14) Have A Place In Your Dividend Portfolio?

Do Insiders Own Lots Of Shares In InnoTek Limited (SGX:M14)?

Jan 21
Do Insiders Own Lots Of Shares In InnoTek Limited (SGX:M14)?

Is It Too Late To Consider Buying InnoTek Limited (SGX:M14)?

Jan 08
Is It Too Late To Consider Buying InnoTek Limited (SGX:M14)?

How Much Did InnoTek's (SGX:M14) CEO Pocket Last Year?

Dec 22
How Much Did InnoTek's (SGX:M14) CEO Pocket Last Year?

InnoTek Limited's (SGX:M14) Intrinsic Value Is Potentially 98% Above Its Share Price

Dec 04
InnoTek Limited's (SGX:M14) Intrinsic Value Is Potentially 98% Above Its Share Price

InnoTek (SGX:M14) Has Gifted Shareholders With A Fantastic 286% Total Return On Their Investment

Nov 19
InnoTek (SGX:M14) Has Gifted Shareholders With A Fantastic 286% Total Return On Their Investment

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( SGD194.7M ) M14 } overtreffen de korte termijn passiva ( SGD92.4M ).

Langlopende schulden: De kortetermijnactiva M14 ( SGD194.7M ) overtreffen de langetermijnschulden ( SGD11.6M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: M14 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van M14 is de afgelopen 5 jaar gestegen van 0% naar 5.2%.

Schuldendekking: De schuld van M14 wordt goed gedekt door de operationele kasstroom ( 164.2% ).

Rentedekking: De rentebetalingen op de schuld van M14 worden goed gedekt door EBIT ( 18.9 x dekking).


Balans


Ontdek gezonde bedrijven